This week in Drug Discovery (12 – 16 January)
News round-up for 12 – 16 January by Bruno Quinney, Content Team at DDW.
This week in DDW, new research in women’s health has uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed?
The top stories:
Discovery reveals endometriosis is not one disorder but many
New research from Paris-based biotech endogene.bio suggests endometriosis is molecularly heterogeneous across patients, lesion sites, and cell types.
Read more…
Therapy could increase ovarian cancer survival, paper finds
A novel DNA-based therapy could increase survival rates for women with platinum-resistant ovarian cancer, a new paper reveals.
Cellular ageing could be reversed, research reveals
A study published in Proceedings of the National Academy of Sciences (PNAS) shows precise modulation of individual transcription factors can reverse core hallmarks of cellular ageing and restore tissue function in vivo.
New research uncovers genetic causes of sight loss
Scientists have uncovered new genetic causes of sight loss, paving the way for a genetic diagnosis for thousands of people.
MHRA reforms boost the UK’s competitiveness for clinical research
The UK is ramping up efforts to become a global first choice for clinical trials, as new figures show a sharp rise in activity in 2025, and changes coming this year – including a fast-track route – designed to help companies get studies up and running more quickly.